nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—UGT1A4—Tamoxifen—breast cancer	0.0966	0.188	CbGbCtD
Midazolam—CYP3A4—breast cancer	0.0898	0.546	CbGaD
Midazolam—ABCB1—breast cancer	0.0748	0.454	CbGaD
Midazolam—CYP2B6—Thiotepa—breast cancer	0.028	0.0543	CbGbCtD
Midazolam—CYP3A5—Lapatinib—breast cancer	0.0194	0.0377	CbGbCtD
Midazolam—CYP2B6—Raloxifene—breast cancer	0.0187	0.0362	CbGbCtD
Midazolam—ABCB1—Toremifene—breast cancer	0.0173	0.0336	CbGbCtD
Midazolam—CYP3A4—Exemestane—breast cancer	0.015	0.029	CbGbCtD
Midazolam—CYP3A7—Tamoxifen—breast cancer	0.013	0.0251	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.013	0.0251	CbGbCtD
Midazolam—CYP3A4—Letrozole—breast cancer	0.0127	0.0247	CbGbCtD
Midazolam—ABCB1—Lapatinib—breast cancer	0.0126	0.0245	CbGbCtD
Midazolam—CYP2E1—Tamoxifen—breast cancer	0.0125	0.0243	CbGbCtD
Midazolam—CYP2B6—Tamoxifen—breast cancer	0.0123	0.0239	CbGbCtD
Midazolam—CYP2E1—Mitoxantrone—breast cancer	0.0122	0.0237	CbGbCtD
Midazolam—CYP3A4—Anastrozole—breast cancer	0.0113	0.022	CbGbCtD
Midazolam—CYP3A4—Toremifene—breast cancer	0.0104	0.0201	CbGbCtD
Midazolam—CYP3A7—Paclitaxel—breast cancer	0.0101	0.0196	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.0101	0.0196	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00994	0.0193	CbGbCtD
Midazolam—CYP3A7—Irinotecan—breast cancer	0.00994	0.0193	CbGbCtD
Midazolam—CYP3A5—Tamoxifen—breast cancer	0.00972	0.0189	CbGbCtD
Midazolam—CYP3A4—Fulvestrant—breast cancer	0.00964	0.0187	CbGbCtD
Midazolam—CYP2B6—Irinotecan—breast cancer	0.00947	0.0184	CbGbCtD
Midazolam—CYP3A4—Thiotepa—breast cancer	0.00859	0.0167	CbGbCtD
Midazolam—CYP3A4—Ixabepilone—breast cancer	0.00786	0.0153	CbGbCtD
Midazolam—CYP3A4—Lapatinib—breast cancer	0.00757	0.0147	CbGbCtD
Midazolam—CYP3A5—Paclitaxel—breast cancer	0.00756	0.0147	CbGbCtD
Midazolam—CYP3A5—Irinotecan—breast cancer	0.00746	0.0145	CbGbCtD
Midazolam—CYP3A7—Docetaxel—breast cancer	0.00729	0.0141	CbGbCtD
Midazolam—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00729	0.0141	CbGbCtD
Midazolam—ABCB1—Vinorelbine—breast cancer	0.007	0.0136	CbGbCtD
Midazolam—ABCB1—Tamoxifen—breast cancer	0.00632	0.0123	CbGbCtD
Midazolam—ABCB1—Mitoxantrone—breast cancer	0.00617	0.012	CbGbCtD
Midazolam—CYP3A4—Raloxifene—breast cancer	0.00573	0.0111	CbGbCtD
Midazolam—CYP3A5—Docetaxel—breast cancer	0.00547	0.0106	CbGbCtD
Midazolam—ABCB1—Gemcitabine—breast cancer	0.00545	0.0106	CbGbCtD
Midazolam—CYP2B6—Doxorubicin—breast cancer	0.00517	0.01	CbGbCtD
Midazolam—ABCB1—Paclitaxel—breast cancer	0.00492	0.00955	CbGbCtD
Midazolam—ABCB1—Irinotecan—breast cancer	0.00486	0.00942	CbGbCtD
Midazolam—ABCB1—Vinblastine—breast cancer	0.00432	0.00838	CbGbCtD
Midazolam—CYP3A4—Vinorelbine—breast cancer	0.0042	0.00814	CbGbCtD
Midazolam—CYP3A4—Tamoxifen—breast cancer	0.00379	0.00735	CbGbCtD
Midazolam—CYP3A4—Mitoxantrone—breast cancer	0.00369	0.00717	CbGbCtD
Midazolam—ABCB1—Docetaxel—breast cancer	0.00356	0.0069	CbGbCtD
Midazolam—CYP3A4—Paclitaxel—breast cancer	0.00295	0.00572	CbGbCtD
Midazolam—CYP3A4—Irinotecan—breast cancer	0.00291	0.00564	CbGbCtD
Midazolam—ABCB1—Doxorubicin—breast cancer	0.00265	0.00515	CbGbCtD
Midazolam—CYP3A4—Vinblastine—breast cancer	0.00259	0.00502	CbGbCtD
Midazolam—ABCB1—Methotrexate—breast cancer	0.00257	0.00499	CbGbCtD
Midazolam—CYP3A4—Docetaxel—breast cancer	0.00213	0.00414	CbGbCtD
Midazolam—CYP3A4—Doxorubicin—breast cancer	0.00159	0.00308	CbGbCtD
Midazolam—GABRP—mammary gland—breast cancer	0.00114	0.0449	CbGeAlD
Midazolam—CYP4B1—endometrium—breast cancer	0.00101	0.0398	CbGeAlD
Midazolam—GABRP—nipple—breast cancer	0.000943	0.0371	CbGeAlD
Midazolam—CYP4B1—uterus—breast cancer	0.000932	0.0367	CbGeAlD
Midazolam—CYP4B1—pituitary gland—breast cancer	0.000915	0.036	CbGeAlD
Midazolam—CYP4B1—adipose tissue—breast cancer	0.000911	0.0359	CbGeAlD
Midazolam—GABRE—mammary gland—breast cancer	0.00087	0.0342	CbGeAlD
Midazolam—CYP4B1—female reproductive system—breast cancer	0.000838	0.033	CbGeAlD
Midazolam—CYP4B1—adrenal gland—breast cancer	0.000818	0.0322	CbGeAlD
Midazolam—CYP4B1—female gonad—breast cancer	0.000762	0.03	CbGeAlD
Midazolam—GABRG3—pituitary gland—breast cancer	0.000744	0.0293	CbGeAlD
Midazolam—GABRE—nipple—breast cancer	0.00072	0.0283	CbGeAlD
Midazolam—UGT1A4—endocrine gland—breast cancer	0.000718	0.0283	CbGeAlD
Midazolam—GABRB1—pituitary gland—breast cancer	0.000575	0.0226	CbGeAlD
Midazolam—GABRP—endometrium—breast cancer	0.000569	0.0224	CbGeAlD
Midazolam—GABRP—uterus—breast cancer	0.000525	0.0206	CbGeAlD
Midazolam—GABRA4—pituitary gland—breast cancer	0.000519	0.0204	CbGeAlD
Midazolam—GABRP—pituitary gland—breast cancer	0.000515	0.0203	CbGeAlD
Midazolam—CYP3A7—endocrine gland—breast cancer	0.000501	0.0197	CbGeAlD
Midazolam—CYP4B1—lymph node—breast cancer	0.00049	0.0193	CbGeAlD
Midazolam—GABRP—female reproductive system—breast cancer	0.000472	0.0186	CbGeAlD
Midazolam—Clonazepam—NAT2—breast cancer	0.000448	0.204	CrCbGaD
Midazolam—GABRE—endometrium—breast cancer	0.000435	0.0171	CbGeAlD
Midazolam—GABRG2—pituitary gland—breast cancer	0.000434	0.0171	CbGeAlD
Midazolam—GABRA3—endocrine gland—breast cancer	0.000413	0.0162	CbGeAlD
Midazolam—GABRA2—adipose tissue—breast cancer	0.000395	0.0155	CbGeAlD
Midazolam—GABRR2—lymph node—breast cancer	0.000394	0.0155	CbGeAlD
Midazolam—GABRE—pituitary gland—breast cancer	0.000393	0.0155	CbGeAlD
Midazolam—GABRE—adipose tissue—breast cancer	0.000392	0.0154	CbGeAlD
Midazolam—SLC22A1—adipose tissue—breast cancer	0.000373	0.0147	CbGeAlD
Midazolam—GABRE—female reproductive system—breast cancer	0.00036	0.0142	CbGeAlD
Midazolam—GABRA2—adrenal gland—breast cancer	0.000354	0.0139	CbGeAlD
Midazolam—GABRE—adrenal gland—breast cancer	0.000351	0.0138	CbGeAlD
Midazolam—GABRB3—pituitary gland—breast cancer	0.000333	0.0131	CbGeAlD
Midazolam—GABRE—female gonad—breast cancer	0.000328	0.0129	CbGeAlD
Midazolam—GABRB3—female reproductive system—breast cancer	0.000305	0.012	CbGeAlD
Midazolam—SLC22A1—endocrine gland—breast cancer	0.00029	0.0114	CbGeAlD
Midazolam—CYP2B6—skin of body—breast cancer	0.000265	0.0104	CbGeAlD
Midazolam—GABRB3—endocrine gland—breast cancer	0.000258	0.0102	CbGeAlD
Midazolam—CYP3A5—adipose tissue—breast cancer	0.000226	0.00891	CbGeAlD
Midazolam—GABRA2—lymph node—breast cancer	0.000212	0.00836	CbGeAlD
Midazolam—GABRE—lymph node—breast cancer	0.000211	0.00829	CbGeAlD
Midazolam—CYP2B6—female reproductive system—breast cancer	0.000207	0.00814	CbGeAlD
Midazolam—CYP2B6—adrenal gland—breast cancer	0.000202	0.00795	CbGeAlD
Midazolam—CYP2E1—female reproductive system—breast cancer	0.000194	0.00764	CbGeAlD
Midazolam—CYP2E1—adrenal gland—breast cancer	0.000189	0.00746	CbGeAlD
Midazolam—CYP3A5—female gonad—breast cancer	0.000189	0.00746	CbGeAlD
Midazolam—ABCB1—embryo—breast cancer	0.000182	0.00718	CbGeAlD
Midazolam—CYP3A5—endocrine gland—breast cancer	0.000176	0.00693	CbGeAlD
Midazolam—CYP2B6—endocrine gland—breast cancer	0.000175	0.00689	CbGeAlD
Midazolam—CYP2E1—endocrine gland—breast cancer	0.000164	0.00647	CbGeAlD
Midazolam—CYP3A4—female reproductive system—breast cancer	0.000156	0.00615	CbGeAlD
Midazolam—ABCB1—epithelium—breast cancer	0.000149	0.00586	CbGeAlD
Midazolam—ABCB1—endometrium—breast cancer	0.000134	0.00525	CbGeAlD
Midazolam—CYP3A4—endocrine gland—breast cancer	0.000132	0.0052	CbGeAlD
Midazolam—ABCB1—uterus—breast cancer	0.000123	0.00484	CbGeAlD
Midazolam—ABCB1—pituitary gland—breast cancer	0.000121	0.00475	CbGeAlD
Midazolam—ABCB1—adipose tissue—breast cancer	0.00012	0.00474	CbGeAlD
Midazolam—ABCB1—female reproductive system—breast cancer	0.000111	0.00435	CbGeAlD
Midazolam—ABCB1—adrenal gland—breast cancer	0.000108	0.00425	CbGeAlD
Midazolam—ABCB1—bone marrow—breast cancer	0.000104	0.00411	CbGeAlD
Midazolam—ABCB1—female gonad—breast cancer	0.000101	0.00396	CbGeAlD
Midazolam—Ketazolam—CYP3A4—breast cancer	0.000101	0.0458	CrCbGaD
Midazolam—Chlordiazepoxide—CYP2D6—breast cancer	9.79e-05	0.0446	CrCbGaD
Midazolam—ABCB1—endocrine gland—breast cancer	9.36e-05	0.00368	CbGeAlD
Midazolam—Ketazolam—ALB—breast cancer	8.78e-05	0.04	CrCbGaD
Midazolam—Chlordiazepoxide—CYP3A4—breast cancer	8.4e-05	0.0382	CrCbGaD
Midazolam—Ketazolam—ABCB1—breast cancer	8.37e-05	0.0381	CrCbGaD
Midazolam—Clonazepam—CYP3A4—breast cancer	8.11e-05	0.0369	CrCbGaD
Midazolam—Clorazepate—CYP3A4—breast cancer	7.85e-05	0.0358	CrCbGaD
Midazolam—Clotiazepam—CYP3A4—breast cancer	7.53e-05	0.0343	CrCbGaD
Midazolam—Alprazolam—CYP3A4—breast cancer	7.11e-05	0.0324	CrCbGaD
Midazolam—Clobazam—CYP3A4—breast cancer	7.11e-05	0.0324	CrCbGaD
Midazolam—Diazepam—PTGS1—breast cancer	7.11e-05	0.0324	CrCbGaD
Midazolam—Clonazepam—ALB—breast cancer	7.07e-05	0.0322	CrCbGaD
Midazolam—Quazepam—CYP3A4—breast cancer	6.89e-05	0.0314	CrCbGaD
Midazolam—Rash—Vinorelbine—breast cancer	6.71e-05	0.000377	CcSEcCtD
Midazolam—Dermatitis—Vinorelbine—breast cancer	6.7e-05	0.000377	CcSEcCtD
Midazolam—Hypotension—Paclitaxel—breast cancer	6.69e-05	0.000376	CcSEcCtD
Midazolam—Urticaria—Fluorouracil—breast cancer	6.67e-05	0.000376	CcSEcCtD
Midazolam—Headache—Vinorelbine—breast cancer	6.66e-05	0.000375	CcSEcCtD
Midazolam—Syncope—Docetaxel—breast cancer	6.66e-05	0.000375	CcSEcCtD
Midazolam—Flunitrazepam—CYP3A4—breast cancer	6.51e-05	0.0296	CrCbGaD
Midazolam—Cough—Docetaxel—breast cancer	6.48e-05	0.000365	CcSEcCtD
Midazolam—ABCB1—lymph node—breast cancer	6.47e-05	0.00255	CbGeAlD
Midazolam—Vertigo—Capecitabine—breast cancer	6.46e-05	0.000364	CcSEcCtD
Midazolam—Hypersensitivity—Mitoxantrone—breast cancer	6.46e-05	0.000364	CcSEcCtD
Midazolam—Hypersensitivity—Irinotecan—breast cancer	6.46e-05	0.000364	CcSEcCtD
Midazolam—Vomiting—Thiotepa—breast cancer	6.46e-05	0.000364	CcSEcCtD
Midazolam—Syncope—Capecitabine—breast cancer	6.45e-05	0.000363	CcSEcCtD
Midazolam—Paraesthesia—Paclitaxel—breast cancer	6.42e-05	0.000362	CcSEcCtD
Midazolam—Drowsiness—Epirubicin—breast cancer	6.41e-05	0.000361	CcSEcCtD
Midazolam—Rash—Thiotepa—breast cancer	6.41e-05	0.000361	CcSEcCtD
Midazolam—Dermatitis—Thiotepa—breast cancer	6.4e-05	0.00036	CcSEcCtD
Midazolam—Dyspnoea—Paclitaxel—breast cancer	6.38e-05	0.000359	CcSEcCtD
Midazolam—Headache—Thiotepa—breast cancer	6.36e-05	0.000358	CcSEcCtD
Midazolam—Somnolence—Paclitaxel—breast cancer	6.36e-05	0.000358	CcSEcCtD
Midazolam—Nausea—Vinorelbine—breast cancer	6.32e-05	0.000356	CcSEcCtD
Midazolam—Dyspepsia—Paclitaxel—breast cancer	6.3e-05	0.000354	CcSEcCtD
Midazolam—Asthenia—Mitoxantrone—breast cancer	6.29e-05	0.000354	CcSEcCtD
Midazolam—Asthenia—Irinotecan—breast cancer	6.29e-05	0.000354	CcSEcCtD
Midazolam—Neuropathy peripheral—Epirubicin—breast cancer	6.29e-05	0.000354	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.28e-05	0.000354	CcSEcCtD
Midazolam—Cough—Capecitabine—breast cancer	6.28e-05	0.000353	CcSEcCtD
Midazolam—Hypersensitivity—Fluorouracil—breast cancer	6.19e-05	0.000348	CcSEcCtD
Midazolam—Dry mouth—Docetaxel—breast cancer	6.19e-05	0.000348	CcSEcCtD
Midazolam—Gastrointestinal disorder—Paclitaxel—breast cancer	6.18e-05	0.000348	CcSEcCtD
Midazolam—Fatigue—Paclitaxel—breast cancer	6.17e-05	0.000347	CcSEcCtD
Midazolam—Asthenia—Gemcitabine—breast cancer	6.13e-05	0.000345	CcSEcCtD
Midazolam—Constipation—Paclitaxel—breast cancer	6.12e-05	0.000344	CcSEcCtD
Midazolam—Pain—Paclitaxel—breast cancer	6.12e-05	0.000344	CcSEcCtD
Midazolam—Confusional state—Docetaxel—breast cancer	6.11e-05	0.000344	CcSEcCtD
Midazolam—Anxiety—Capecitabine—breast cancer	6.1e-05	0.000344	CcSEcCtD
Midazolam—Estazolam—CYP3A4—breast cancer	6.09e-05	0.0277	CrCbGaD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	6.08e-05	0.000342	CcSEcCtD
Midazolam—Anaphylactic shock—Docetaxel—breast cancer	6.06e-05	0.000341	CcSEcCtD
Midazolam—Pruritus—Gemcitabine—breast cancer	6.05e-05	0.00034	CcSEcCtD
Midazolam—Nausea—Thiotepa—breast cancer	6.03e-05	0.00034	CcSEcCtD
Midazolam—Dry mouth—Capecitabine—breast cancer	5.99e-05	0.000337	CcSEcCtD
Midazolam—Shock—Docetaxel—breast cancer	5.97e-05	0.000336	CcSEcCtD
Midazolam—Nervous system disorder—Docetaxel—breast cancer	5.95e-05	0.000335	CcSEcCtD
Midazolam—Pruritus—Fluorouracil—breast cancer	5.94e-05	0.000335	CcSEcCtD
Midazolam—Drowsiness—Doxorubicin—breast cancer	5.93e-05	0.000334	CcSEcCtD
Midazolam—Visual impairment—Methotrexate—breast cancer	5.93e-05	0.000334	CcSEcCtD
Midazolam—Confusional state—Capecitabine—breast cancer	5.92e-05	0.000333	CcSEcCtD
Midazolam—Clobazam—ABCB1—breast cancer	5.92e-05	0.027	CrCbGaD
Midazolam—Tachycardia—Docetaxel—breast cancer	5.92e-05	0.000333	CcSEcCtD
Midazolam—Feeling abnormal—Paclitaxel—breast cancer	5.9e-05	0.000332	CcSEcCtD
Midazolam—Skin disorder—Docetaxel—breast cancer	5.89e-05	0.000332	CcSEcCtD
Midazolam—Bradycardia—Epirubicin—breast cancer	5.86e-05	0.00033	CcSEcCtD
Midazolam—Neuropathy peripheral—Doxorubicin—breast cancer	5.82e-05	0.000327	CcSEcCtD
Midazolam—Dizziness—Irinotecan—breast cancer	5.8e-05	0.000327	CcSEcCtD
Midazolam—Adinazolam—CYP3A4—breast cancer	5.8e-05	0.0264	CrCbGaD
Midazolam—Shock—Capecitabine—breast cancer	5.78e-05	0.000325	CcSEcCtD
Midazolam—Nervous system disorder—Capecitabine—breast cancer	5.76e-05	0.000324	CcSEcCtD
Midazolam—Eye disorder—Methotrexate—breast cancer	5.75e-05	0.000324	CcSEcCtD
Midazolam—Tachycardia—Capecitabine—breast cancer	5.73e-05	0.000323	CcSEcCtD
Midazolam—Cardiac disorder—Methotrexate—breast cancer	5.71e-05	0.000321	CcSEcCtD
Midazolam—Skin disorder—Capecitabine—breast cancer	5.7e-05	0.000321	CcSEcCtD
Midazolam—Urticaria—Paclitaxel—breast cancer	5.68e-05	0.00032	CcSEcCtD
Midazolam—Hypotension—Docetaxel—breast cancer	5.67e-05	0.000319	CcSEcCtD
Midazolam—Connective tissue disorder—Epirubicin—breast cancer	5.66e-05	0.000318	CcSEcCtD
Midazolam—Prazepam—CYP3A4—breast cancer	5.6e-05	0.0255	CrCbGaD
Midazolam—Vomiting—Mitoxantrone—breast cancer	5.58e-05	0.000314	CcSEcCtD
Midazolam—Vomiting—Irinotecan—breast cancer	5.58e-05	0.000314	CcSEcCtD
Midazolam—Immune system disorder—Methotrexate—breast cancer	5.56e-05	0.000313	CcSEcCtD
Midazolam—Dizziness—Fluorouracil—breast cancer	5.56e-05	0.000313	CcSEcCtD
Midazolam—Visual impairment—Epirubicin—breast cancer	5.55e-05	0.000312	CcSEcCtD
Midazolam—Mediastinal disorder—Methotrexate—breast cancer	5.54e-05	0.000312	CcSEcCtD
Midazolam—Rash—Irinotecan—breast cancer	5.53e-05	0.000311	CcSEcCtD
Midazolam—Rash—Mitoxantrone—breast cancer	5.53e-05	0.000311	CcSEcCtD
Midazolam—Dermatitis—Mitoxantrone—breast cancer	5.53e-05	0.000311	CcSEcCtD
Midazolam—Dermatitis—Irinotecan—breast cancer	5.53e-05	0.000311	CcSEcCtD
Midazolam—Chills—Methotrexate—breast cancer	5.52e-05	0.000311	CcSEcCtD
Midazolam—Headache—Irinotecan—breast cancer	5.5e-05	0.000309	CcSEcCtD
Midazolam—Headache—Mitoxantrone—breast cancer	5.5e-05	0.000309	CcSEcCtD
Midazolam—Hypotension—Capecitabine—breast cancer	5.49e-05	0.000309	CcSEcCtD
Midazolam—Paraesthesia—Docetaxel—breast cancer	5.45e-05	0.000306	CcSEcCtD
Midazolam—Vomiting—Gemcitabine—breast cancer	5.43e-05	0.000306	CcSEcCtD
Midazolam—Bradycardia—Doxorubicin—breast cancer	5.42e-05	0.000305	CcSEcCtD
Midazolam—Dyspnoea—Docetaxel—breast cancer	5.41e-05	0.000304	CcSEcCtD
Midazolam—Somnolence—Docetaxel—breast cancer	5.39e-05	0.000303	CcSEcCtD
Midazolam—Mental disorder—Methotrexate—breast cancer	5.39e-05	0.000303	CcSEcCtD
Midazolam—Rash—Gemcitabine—breast cancer	5.39e-05	0.000303	CcSEcCtD
Midazolam—Dermatitis—Gemcitabine—breast cancer	5.38e-05	0.000303	CcSEcCtD
Midazolam—Eye disorder—Epirubicin—breast cancer	5.38e-05	0.000303	CcSEcCtD
Midazolam—Erythema—Methotrexate—breast cancer	5.36e-05	0.000301	CcSEcCtD
Midazolam—Headache—Gemcitabine—breast cancer	5.35e-05	0.000301	CcSEcCtD
Midazolam—Cardiac disorder—Epirubicin—breast cancer	5.34e-05	0.000301	CcSEcCtD
Midazolam—Vomiting—Fluorouracil—breast cancer	5.34e-05	0.000301	CcSEcCtD
Midazolam—Dyspepsia—Docetaxel—breast cancer	5.34e-05	0.0003	CcSEcCtD
Midazolam—Rash—Fluorouracil—breast cancer	5.3e-05	0.000298	CcSEcCtD
Midazolam—Dermatitis—Fluorouracil—breast cancer	5.29e-05	0.000298	CcSEcCtD
Midazolam—Paraesthesia—Capecitabine—breast cancer	5.27e-05	0.000297	CcSEcCtD
Midazolam—Hypersensitivity—Paclitaxel—breast cancer	5.27e-05	0.000297	CcSEcCtD
Midazolam—Headache—Fluorouracil—breast cancer	5.26e-05	0.000296	CcSEcCtD
Midazolam—Gastrointestinal disorder—Docetaxel—breast cancer	5.24e-05	0.000295	CcSEcCtD
Midazolam—Connective tissue disorder—Doxorubicin—breast cancer	5.23e-05	0.000295	CcSEcCtD
Midazolam—Dyspnoea—Capecitabine—breast cancer	5.23e-05	0.000295	CcSEcCtD
Midazolam—Fatigue—Docetaxel—breast cancer	5.23e-05	0.000294	CcSEcCtD
Midazolam—Flurazepam—CYP3A4—breast cancer	5.23e-05	0.0238	CrCbGaD
Midazolam—Triazolam—CYP3A4—breast cancer	5.22e-05	0.0238	CrCbGaD
Midazolam—Nausea—Mitoxantrone—breast cancer	5.21e-05	0.000293	CcSEcCtD
Midazolam—Nausea—Irinotecan—breast cancer	5.21e-05	0.000293	CcSEcCtD
Midazolam—Immune system disorder—Epirubicin—breast cancer	5.2e-05	0.000293	CcSEcCtD
Midazolam—Mediastinal disorder—Epirubicin—breast cancer	5.19e-05	0.000292	CcSEcCtD
Midazolam—Pain—Docetaxel—breast cancer	5.19e-05	0.000292	CcSEcCtD
Midazolam—Constipation—Docetaxel—breast cancer	5.19e-05	0.000292	CcSEcCtD
Midazolam—Dyspepsia—Capecitabine—breast cancer	5.17e-05	0.000291	CcSEcCtD
Midazolam—Chills—Epirubicin—breast cancer	5.17e-05	0.000291	CcSEcCtD
Midazolam—Visual impairment—Doxorubicin—breast cancer	5.13e-05	0.000289	CcSEcCtD
Midazolam—Asthenia—Paclitaxel—breast cancer	5.13e-05	0.000289	CcSEcCtD
Midazolam—Nausea—Gemcitabine—breast cancer	5.08e-05	0.000286	CcSEcCtD
Midazolam—Gastrointestinal disorder—Capecitabine—breast cancer	5.07e-05	0.000285	CcSEcCtD
Midazolam—Fatigue—Capecitabine—breast cancer	5.06e-05	0.000285	CcSEcCtD
Midazolam—Pruritus—Paclitaxel—breast cancer	5.06e-05	0.000285	CcSEcCtD
Midazolam—Oxazepam—CYP3A4—breast cancer	5.06e-05	0.023	CrCbGaD
Midazolam—Vision blurred—Methotrexate—breast cancer	5.05e-05	0.000284	CcSEcCtD
Midazolam—Mental disorder—Epirubicin—breast cancer	5.04e-05	0.000284	CcSEcCtD
Midazolam—Pain—Capecitabine—breast cancer	5.02e-05	0.000283	CcSEcCtD
Midazolam—Constipation—Capecitabine—breast cancer	5.02e-05	0.000283	CcSEcCtD
Midazolam—Erythema—Epirubicin—breast cancer	5.01e-05	0.000282	CcSEcCtD
Midazolam—Feeling abnormal—Docetaxel—breast cancer	5e-05	0.000281	CcSEcCtD
Midazolam—Temazepam—CYP3A4—breast cancer	5e-05	0.0227	CrCbGaD
Midazolam—Nausea—Fluorouracil—breast cancer	4.99e-05	0.000281	CcSEcCtD
Midazolam—Eye disorder—Doxorubicin—breast cancer	4.98e-05	0.00028	CcSEcCtD
Midazolam—Cardiac disorder—Doxorubicin—breast cancer	4.94e-05	0.000278	CcSEcCtD
Midazolam—Tension—Epirubicin—breast cancer	4.92e-05	0.000277	CcSEcCtD
Midazolam—Nervousness—Epirubicin—breast cancer	4.87e-05	0.000274	CcSEcCtD
Midazolam—Feeling abnormal—Capecitabine—breast cancer	4.84e-05	0.000272	CcSEcCtD
Midazolam—Immune system disorder—Doxorubicin—breast cancer	4.81e-05	0.000271	CcSEcCtD
Midazolam—Vertigo—Methotrexate—breast cancer	4.81e-05	0.000271	CcSEcCtD
Midazolam—Mediastinal disorder—Doxorubicin—breast cancer	4.8e-05	0.00027	CcSEcCtD
Midazolam—Chills—Doxorubicin—breast cancer	4.78e-05	0.000269	CcSEcCtD
Midazolam—Dizziness—Paclitaxel—breast cancer	4.73e-05	0.000266	CcSEcCtD
Midazolam—Vision blurred—Epirubicin—breast cancer	4.72e-05	0.000266	CcSEcCtD
Midazolam—Cough—Methotrexate—breast cancer	4.67e-05	0.000263	CcSEcCtD
Midazolam—Mental disorder—Doxorubicin—breast cancer	4.67e-05	0.000263	CcSEcCtD
Midazolam—Urticaria—Capecitabine—breast cancer	4.66e-05	0.000263	CcSEcCtD
Midazolam—Chlorprothixene—ABCB1—breast cancer	4.66e-05	0.0212	CrCbGaD
Midazolam—Erythema—Doxorubicin—breast cancer	4.64e-05	0.000261	CcSEcCtD
Midazolam—Agitation—Epirubicin—breast cancer	4.61e-05	0.000259	CcSEcCtD
Midazolam—Tension—Doxorubicin—breast cancer	4.55e-05	0.000256	CcSEcCtD
Midazolam—Vomiting—Paclitaxel—breast cancer	4.55e-05	0.000256	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.53e-05	0.000255	CcSEcCtD
Midazolam—Rash—Paclitaxel—breast cancer	4.51e-05	0.000254	CcSEcCtD
Midazolam—Dermatitis—Paclitaxel—breast cancer	4.51e-05	0.000254	CcSEcCtD
Midazolam—Nervousness—Doxorubicin—breast cancer	4.5e-05	0.000254	CcSEcCtD
Midazolam—Vertigo—Epirubicin—breast cancer	4.5e-05	0.000253	CcSEcCtD
Midazolam—Syncope—Epirubicin—breast cancer	4.49e-05	0.000253	CcSEcCtD
Midazolam—Headache—Paclitaxel—breast cancer	4.48e-05	0.000252	CcSEcCtD
Midazolam—Hypersensitivity—Docetaxel—breast cancer	4.47e-05	0.000251	CcSEcCtD
Midazolam—Confusional state—Methotrexate—breast cancer	4.41e-05	0.000248	CcSEcCtD
Midazolam—Cough—Epirubicin—breast cancer	4.37e-05	0.000246	CcSEcCtD
Midazolam—Anaphylactic shock—Methotrexate—breast cancer	4.37e-05	0.000246	CcSEcCtD
Midazolam—Vision blurred—Doxorubicin—breast cancer	4.37e-05	0.000246	CcSEcCtD
Midazolam—Asthenia—Docetaxel—breast cancer	4.35e-05	0.000245	CcSEcCtD
Midazolam—Flurazepam—ABCB1—breast cancer	4.35e-05	0.0198	CrCbGaD
Midazolam—Hypersensitivity—Capecitabine—breast cancer	4.33e-05	0.000243	CcSEcCtD
Midazolam—Pruritus—Docetaxel—breast cancer	4.29e-05	0.000241	CcSEcCtD
Midazolam—Nervous system disorder—Methotrexate—breast cancer	4.29e-05	0.000241	CcSEcCtD
Midazolam—Agitation—Doxorubicin—breast cancer	4.26e-05	0.00024	CcSEcCtD
Midazolam—Anxiety—Epirubicin—breast cancer	4.25e-05	0.000239	CcSEcCtD
Midazolam—Nausea—Paclitaxel—breast cancer	4.25e-05	0.000239	CcSEcCtD
Midazolam—Skin disorder—Methotrexate—breast cancer	4.25e-05	0.000239	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.24e-05	0.000239	CcSEcCtD
Midazolam—Asthenia—Capecitabine—breast cancer	4.21e-05	0.000237	CcSEcCtD
Midazolam—Dry mouth—Epirubicin—breast cancer	4.17e-05	0.000235	CcSEcCtD
Midazolam—Vertigo—Doxorubicin—breast cancer	4.17e-05	0.000235	CcSEcCtD
Midazolam—Syncope—Doxorubicin—breast cancer	4.16e-05	0.000234	CcSEcCtD
Midazolam—Pruritus—Capecitabine—breast cancer	4.15e-05	0.000234	CcSEcCtD
Midazolam—Diazepam—CYP3A4—breast cancer	4.15e-05	0.0189	CrCbGaD
Midazolam—Confusional state—Epirubicin—breast cancer	4.12e-05	0.000232	CcSEcCtD
Midazolam—Anaphylactic shock—Epirubicin—breast cancer	4.09e-05	0.00023	CcSEcCtD
Midazolam—Hypotension—Methotrexate—breast cancer	4.08e-05	0.00023	CcSEcCtD
Midazolam—Cough—Doxorubicin—breast cancer	4.05e-05	0.000228	CcSEcCtD
Midazolam—Shock—Epirubicin—breast cancer	4.02e-05	0.000227	CcSEcCtD
Midazolam—Nervous system disorder—Epirubicin—breast cancer	4.01e-05	0.000226	CcSEcCtD
Midazolam—Dizziness—Docetaxel—breast cancer	4.01e-05	0.000226	CcSEcCtD
Midazolam—Tachycardia—Epirubicin—breast cancer	3.99e-05	0.000225	CcSEcCtD
Midazolam—Skin disorder—Epirubicin—breast cancer	3.97e-05	0.000224	CcSEcCtD
Midazolam—Anxiety—Doxorubicin—breast cancer	3.93e-05	0.000221	CcSEcCtD
Midazolam—Paraesthesia—Methotrexate—breast cancer	3.92e-05	0.000221	CcSEcCtD
Midazolam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.92e-05	0.000221	CcSEcCtD
Midazolam—Dyspnoea—Methotrexate—breast cancer	3.9e-05	0.000219	CcSEcCtD
Midazolam—Somnolence—Methotrexate—breast cancer	3.89e-05	0.000219	CcSEcCtD
Midazolam—Dizziness—Capecitabine—breast cancer	3.88e-05	0.000219	CcSEcCtD
Midazolam—Dry mouth—Doxorubicin—breast cancer	3.86e-05	0.000217	CcSEcCtD
Midazolam—Vomiting—Docetaxel—breast cancer	3.86e-05	0.000217	CcSEcCtD
Midazolam—Dyspepsia—Methotrexate—breast cancer	3.85e-05	0.000217	CcSEcCtD
Midazolam—Rash—Docetaxel—breast cancer	3.82e-05	0.000215	CcSEcCtD
Midazolam—Hypotension—Epirubicin—breast cancer	3.82e-05	0.000215	CcSEcCtD
Midazolam—Dermatitis—Docetaxel—breast cancer	3.82e-05	0.000215	CcSEcCtD
Midazolam—Confusional state—Doxorubicin—breast cancer	3.82e-05	0.000215	CcSEcCtD
Midazolam—Headache—Docetaxel—breast cancer	3.8e-05	0.000214	CcSEcCtD
Midazolam—Anaphylactic shock—Doxorubicin—breast cancer	3.78e-05	0.000213	CcSEcCtD
Midazolam—Gastrointestinal disorder—Methotrexate—breast cancer	3.77e-05	0.000212	CcSEcCtD
Midazolam—Fatigue—Methotrexate—breast cancer	3.77e-05	0.000212	CcSEcCtD
Midazolam—Pain—Methotrexate—breast cancer	3.74e-05	0.00021	CcSEcCtD
Midazolam—Vomiting—Capecitabine—breast cancer	3.73e-05	0.00021	CcSEcCtD
Midazolam—Shock—Doxorubicin—breast cancer	3.72e-05	0.00021	CcSEcCtD
Midazolam—Nervous system disorder—Doxorubicin—breast cancer	3.71e-05	0.000209	CcSEcCtD
Midazolam—Rash—Capecitabine—breast cancer	3.7e-05	0.000208	CcSEcCtD
Midazolam—Dermatitis—Capecitabine—breast cancer	3.7e-05	0.000208	CcSEcCtD
Midazolam—Tachycardia—Doxorubicin—breast cancer	3.69e-05	0.000208	CcSEcCtD
Midazolam—Headache—Capecitabine—breast cancer	3.68e-05	0.000207	CcSEcCtD
Midazolam—Skin disorder—Doxorubicin—breast cancer	3.68e-05	0.000207	CcSEcCtD
Midazolam—Paraesthesia—Epirubicin—breast cancer	3.67e-05	0.000207	CcSEcCtD
Midazolam—Dyspnoea—Epirubicin—breast cancer	3.65e-05	0.000205	CcSEcCtD
Midazolam—Somnolence—Epirubicin—breast cancer	3.64e-05	0.000205	CcSEcCtD
Midazolam—Diazepam—ALB—breast cancer	3.62e-05	0.0165	CrCbGaD
Midazolam—Nausea—Docetaxel—breast cancer	3.6e-05	0.000203	CcSEcCtD
Midazolam—Feeling abnormal—Methotrexate—breast cancer	3.6e-05	0.000203	CcSEcCtD
Midazolam—Dyspepsia—Epirubicin—breast cancer	3.6e-05	0.000203	CcSEcCtD
Midazolam—Hypotension—Doxorubicin—breast cancer	3.54e-05	0.000199	CcSEcCtD
Midazolam—Gastrointestinal disorder—Epirubicin—breast cancer	3.53e-05	0.000199	CcSEcCtD
Midazolam—Fatigue—Epirubicin—breast cancer	3.53e-05	0.000198	CcSEcCtD
Midazolam—Pain—Epirubicin—breast cancer	3.5e-05	0.000197	CcSEcCtD
Midazolam—Constipation—Epirubicin—breast cancer	3.5e-05	0.000197	CcSEcCtD
Midazolam—Nausea—Capecitabine—breast cancer	3.49e-05	0.000196	CcSEcCtD
Midazolam—Urticaria—Methotrexate—breast cancer	3.47e-05	0.000195	CcSEcCtD
Midazolam—Diazepam—ABCB1—breast cancer	3.46e-05	0.0157	CrCbGaD
Midazolam—Paraesthesia—Doxorubicin—breast cancer	3.4e-05	0.000191	CcSEcCtD
Midazolam—Dyspnoea—Doxorubicin—breast cancer	3.37e-05	0.00019	CcSEcCtD
Midazolam—Feeling abnormal—Epirubicin—breast cancer	3.37e-05	0.00019	CcSEcCtD
Midazolam—Somnolence—Doxorubicin—breast cancer	3.36e-05	0.000189	CcSEcCtD
Midazolam—Dyspepsia—Doxorubicin—breast cancer	3.33e-05	0.000188	CcSEcCtD
Midazolam—Gastrointestinal disorder—Doxorubicin—breast cancer	3.27e-05	0.000184	CcSEcCtD
Midazolam—Fatigue—Doxorubicin—breast cancer	3.26e-05	0.000184	CcSEcCtD
Midazolam—Urticaria—Epirubicin—breast cancer	3.25e-05	0.000183	CcSEcCtD
Midazolam—Pain—Doxorubicin—breast cancer	3.24e-05	0.000182	CcSEcCtD
Midazolam—Constipation—Doxorubicin—breast cancer	3.24e-05	0.000182	CcSEcCtD
Midazolam—Hypersensitivity—Methotrexate—breast cancer	3.22e-05	0.000181	CcSEcCtD
Midazolam—Asthenia—Methotrexate—breast cancer	3.14e-05	0.000177	CcSEcCtD
Midazolam—Feeling abnormal—Doxorubicin—breast cancer	3.12e-05	0.000176	CcSEcCtD
Midazolam—Pruritus—Methotrexate—breast cancer	3.09e-05	0.000174	CcSEcCtD
Midazolam—Hypersensitivity—Epirubicin—breast cancer	3.01e-05	0.00017	CcSEcCtD
Midazolam—Urticaria—Doxorubicin—breast cancer	3.01e-05	0.000169	CcSEcCtD
Midazolam—Asthenia—Epirubicin—breast cancer	2.93e-05	0.000165	CcSEcCtD
Midazolam—Pruritus—Epirubicin—breast cancer	2.89e-05	0.000163	CcSEcCtD
Midazolam—Dizziness—Methotrexate—breast cancer	2.89e-05	0.000163	CcSEcCtD
Midazolam—Hypersensitivity—Doxorubicin—breast cancer	2.79e-05	0.000157	CcSEcCtD
Midazolam—Vomiting—Methotrexate—breast cancer	2.78e-05	0.000156	CcSEcCtD
Midazolam—Rash—Methotrexate—breast cancer	2.76e-05	0.000155	CcSEcCtD
Midazolam—Dermatitis—Methotrexate—breast cancer	2.75e-05	0.000155	CcSEcCtD
Midazolam—Headache—Methotrexate—breast cancer	2.74e-05	0.000154	CcSEcCtD
Midazolam—Asthenia—Doxorubicin—breast cancer	2.72e-05	0.000153	CcSEcCtD
Midazolam—Dizziness—Epirubicin—breast cancer	2.7e-05	0.000152	CcSEcCtD
Midazolam—Pruritus—Doxorubicin—breast cancer	2.68e-05	0.000151	CcSEcCtD
Midazolam—Vomiting—Epirubicin—breast cancer	2.6e-05	0.000146	CcSEcCtD
Midazolam—Nausea—Methotrexate—breast cancer	2.6e-05	0.000146	CcSEcCtD
Midazolam—Rash—Epirubicin—breast cancer	2.58e-05	0.000145	CcSEcCtD
Midazolam—Dermatitis—Epirubicin—breast cancer	2.58e-05	0.000145	CcSEcCtD
Midazolam—Headache—Epirubicin—breast cancer	2.56e-05	0.000144	CcSEcCtD
Midazolam—Dizziness—Doxorubicin—breast cancer	2.5e-05	0.000141	CcSEcCtD
Midazolam—Nausea—Epirubicin—breast cancer	2.43e-05	0.000137	CcSEcCtD
Midazolam—Vomiting—Doxorubicin—breast cancer	2.41e-05	0.000135	CcSEcCtD
Midazolam—Rash—Doxorubicin—breast cancer	2.39e-05	0.000134	CcSEcCtD
Midazolam—Dermatitis—Doxorubicin—breast cancer	2.38e-05	0.000134	CcSEcCtD
Midazolam—Headache—Doxorubicin—breast cancer	2.37e-05	0.000133	CcSEcCtD
Midazolam—Nausea—Doxorubicin—breast cancer	2.25e-05	0.000127	CcSEcCtD
Midazolam—CYP3A7—Metabolism—CYP1A1—breast cancer	3.97e-06	3.46e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NQO1—breast cancer	3.96e-06	3.45e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SLC2A1—breast cancer	3.96e-06	3.45e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SLC2A1—breast cancer	3.95e-06	3.44e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NQO1—breast cancer	3.95e-06	3.44e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TYMS—breast cancer	3.94e-06	3.43e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPI—breast cancer	3.94e-06	3.43e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HADHB—breast cancer	3.94e-06	3.43e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP3A4—breast cancer	3.94e-06	3.43e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ERCC2—breast cancer	3.94e-06	3.43e-05	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—AKT1—breast cancer	3.93e-06	3.42e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NCOR1—breast cancer	3.9e-06	3.39e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GSTM1—breast cancer	3.9e-06	3.39e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PLA2G4A—breast cancer	3.9e-06	3.39e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOA3—breast cancer	3.88e-06	3.38e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1B1—breast cancer	3.88e-06	3.37e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP3A4—breast cancer	3.86e-06	3.36e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP3A4—breast cancer	3.85e-06	3.36e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC2A2—breast cancer	3.85e-06	3.35e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HSP90AA1—breast cancer	3.8e-06	3.31e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1B1—breast cancer	3.8e-06	3.31e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1B1—breast cancer	3.79e-06	3.3e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CPT1A—breast cancer	3.77e-06	3.28e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTR—breast cancer	3.77e-06	3.28e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ABCG2—breast cancer	3.77e-06	3.28e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.76e-06	3.28e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.76e-06	3.28e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—GPX1—breast cancer	3.73e-06	3.25e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HSP90AA1—breast cancer	3.72e-06	3.24e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HSP90AA1—breast cancer	3.71e-06	3.23e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MTHFR—breast cancer	3.7e-06	3.22e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HPGDS—breast cancer	3.7e-06	3.22e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NCOA1—breast cancer	3.7e-06	3.22e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CYP1A1—breast cancer	3.7e-06	3.22e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HBA1—breast cancer	3.68e-06	3.2e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ERCC2—breast cancer	3.67e-06	3.19e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—STK11—breast cancer	3.64e-06	3.17e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP19A1—breast cancer	3.64e-06	3.17e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NCOA1—breast cancer	3.62e-06	3.15e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NCOA1—breast cancer	3.61e-06	3.15e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADSL—breast cancer	3.61e-06	3.14e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PHGDH—breast cancer	3.61e-06	3.14e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NME1—breast cancer	3.61e-06	3.14e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—UMPS—breast cancer	3.61e-06	3.14e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FHL2—breast cancer	3.61e-06	3.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ACHE—breast cancer	3.59e-06	3.12e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTT1—breast cancer	3.59e-06	3.12e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—STK11—breast cancer	3.57e-06	3.11e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP19A1—breast cancer	3.57e-06	3.11e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—STK11—breast cancer	3.56e-06	3.1e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP19A1—breast cancer	3.56e-06	3.1e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HPSE—breast cancer	3.54e-06	3.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—LDHB—breast cancer	3.54e-06	3.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BRIP1—breast cancer	3.54e-06	3.08e-05	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—breast cancer	3.48e-06	3.03e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MTHFR—breast cancer	3.45e-06	3e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CAV1—breast cancer	3.41e-06	2.97e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP17A1—breast cancer	3.4e-06	2.96e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—COMT—breast cancer	3.39e-06	2.95e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTP1—breast cancer	3.37e-06	2.94e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS1—breast cancer	3.36e-06	2.93e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ENO1—breast cancer	3.36e-06	2.93e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA3—breast cancer	3.35e-06	2.92e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMMR—breast cancer	3.35e-06	2.92e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCC1—breast cancer	3.35e-06	2.92e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—HMOX1—breast cancer	3.32e-06	2.9e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—COMT—breast cancer	3.32e-06	2.89e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ITPR1—breast cancer	3.32e-06	2.89e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—COMT—breast cancer	3.31e-06	2.88e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTP1—breast cancer	3.3e-06	2.88e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP2D6—breast cancer	3.3e-06	2.87e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTP1—breast cancer	3.3e-06	2.87e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—HMOX1—breast cancer	3.26e-06	2.84e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—HMOX1—breast cancer	3.25e-06	2.83e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ITPR1—breast cancer	3.25e-06	2.83e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.25e-06	2.83e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ITPR1—breast cancer	3.24e-06	2.82e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOA2—breast cancer	3.24e-06	2.82e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ABCB1—breast cancer	3.19e-06	2.78e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CAV1—breast cancer	3.18e-06	2.77e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—ALB—breast cancer	3.14e-06	2.74e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—FASN—breast cancer	3.14e-06	2.73e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TYMS—breast cancer	3.13e-06	2.73e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ABCB1—breast cancer	3.13e-06	2.72e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—BCHE—breast cancer	3.13e-06	2.72e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ABCB1—breast cancer	3.12e-06	2.72e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CG—breast cancer	3.11e-06	2.71e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NCOR1—breast cancer	3.1e-06	2.7e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GSTM1—breast cancer	3.1e-06	2.7e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PLA2G4A—breast cancer	3.1e-06	2.7e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC5A5—breast cancer	3.09e-06	2.69e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TYMS—breast cancer	3.07e-06	2.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA4—breast cancer	3.07e-06	2.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CA9—breast cancer	3.07e-06	2.67e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TYMS—breast cancer	3.06e-06	2.67e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GSTM1—breast cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PLA2G4A—breast cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NCOR1—breast cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PLA2G4A—breast cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GSTM1—breast cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NCOR1—breast cancer	3.03e-06	2.64e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—PIK3CA—breast cancer	3.01e-06	2.62e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX2—breast cancer	2.99e-06	2.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA2—breast cancer	2.99e-06	2.6e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SLC2A1—breast cancer	2.98e-06	2.6e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NQO1—breast cancer	2.98e-06	2.6e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—GPX1—breast cancer	2.97e-06	2.58e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SULT1A1—breast cancer	2.95e-06	2.57e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX4—breast cancer	2.95e-06	2.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CYP1A1—breast cancer	2.94e-06	2.56e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ERCC2—breast cancer	2.91e-06	2.54e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP3A4—breast cancer	2.91e-06	2.53e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—GPX1—breast cancer	2.91e-06	2.53e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—GPX1—breast cancer	2.9e-06	2.53e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CG—breast cancer	2.89e-06	2.52e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTA1—breast cancer	2.88e-06	2.51e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—IDH1—breast cancer	2.88e-06	2.51e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CYP1A1—breast cancer	2.88e-06	2.5e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CYP1A1—breast cancer	2.87e-06	2.5e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1B1—breast cancer	2.86e-06	2.49e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ERCC2—breast cancer	2.85e-06	2.48e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NAT2—breast cancer	2.85e-06	2.48e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ERCC2—breast cancer	2.85e-06	2.48e-05	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	2.84e-06	2.48e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HSP90AA1—breast cancer	2.8e-06	2.44e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MTHFR—breast cancer	2.74e-06	2.38e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CD—breast cancer	2.73e-06	2.38e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOA1—breast cancer	2.73e-06	2.37e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ALB—breast cancer	2.7e-06	2.35e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—STK11—breast cancer	2.69e-06	2.34e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP19A1—breast cancer	2.69e-06	2.34e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MTHFR—breast cancer	2.68e-06	2.34e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MTHFR—breast cancer	2.68e-06	2.33e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—NOS3—breast cancer	2.58e-06	2.25e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CD—breast cancer	2.54e-06	2.22e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CAV1—breast cancer	2.53e-06	2.2e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ALB—breast cancer	2.51e-06	2.19e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—DPYD—breast cancer	2.5e-06	2.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MED12—breast cancer	2.5e-06	2.18e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—COMT—breast cancer	2.5e-06	2.18e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTP1—breast cancer	2.49e-06	2.17e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CAV1—breast cancer	2.47e-06	2.15e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CAV1—breast cancer	2.47e-06	2.15e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALDOA—breast cancer	2.46e-06	2.14e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—AKT1—breast cancer	2.46e-06	2.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—HMOX1—breast cancer	2.45e-06	2.14e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ITPR1—breast cancer	2.45e-06	2.13e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—NOS3—breast cancer	2.4e-06	2.09e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOA3—breast cancer	2.39e-06	2.08e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CB—breast cancer	2.38e-06	2.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC2A2—breast cancer	2.37e-06	2.07e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTGS2—breast cancer	2.36e-06	2.06e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CPT1A—breast cancer	2.32e-06	2.02e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTR—breast cancer	2.32e-06	2.02e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCG2—breast cancer	2.32e-06	2.02e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TYMS—breast cancer	2.31e-06	2.01e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CG—breast cancer	2.3e-06	2e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GSTM1—breast cancer	2.28e-06	1.99e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NCOR1—breast cancer	2.28e-06	1.99e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PLA2G4A—breast cancer	2.28e-06	1.99e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HPGDS—breast cancer	2.28e-06	1.98e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HBA1—breast cancer	2.26e-06	1.97e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CG—breast cancer	2.25e-06	1.96e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CG—breast cancer	2.25e-06	1.96e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CB—breast cancer	2.22e-06	1.93e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ACHE—breast cancer	2.21e-06	1.92e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTT1—breast cancer	2.21e-06	1.92e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTGS2—breast cancer	2.2e-06	1.91e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—GPX1—breast cancer	2.19e-06	1.91e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CYP1A1—breast cancer	2.17e-06	1.89e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ERCC2—breast cancer	2.15e-06	1.87e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP17A1—breast cancer	2.09e-06	1.82e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ENO1—breast cancer	2.07e-06	1.8e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS1—breast cancer	2.07e-06	1.8e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PTEN—breast cancer	2.06e-06	1.79e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP2D6—breast cancer	2.03e-06	1.77e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CD—breast cancer	2.02e-06	1.76e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MTHFR—breast cancer	2.02e-06	1.76e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ALB—breast cancer	2e-06	1.74e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOA2—breast cancer	1.99e-06	1.74e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CD—breast cancer	1.98e-06	1.72e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CD—breast cancer	1.98e-06	1.72e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ALB—breast cancer	1.96e-06	1.7e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ALB—breast cancer	1.95e-06	1.7e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—FASN—breast cancer	1.93e-06	1.68e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—BCHE—breast cancer	1.93e-06	1.68e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PTEN—breast cancer	1.92e-06	1.67e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—NOS3—breast cancer	1.91e-06	1.66e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC5A5—breast cancer	1.9e-06	1.66e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—NOS3—breast cancer	1.87e-06	1.63e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—NOS3—breast cancer	1.87e-06	1.63e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CAV1—breast cancer	1.86e-06	1.62e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NQO1—breast cancer	1.84e-06	1.6e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SLC2A1—breast cancer	1.84e-06	1.6e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CB—breast cancer	1.76e-06	1.53e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1B1—breast cancer	1.76e-06	1.53e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTGS2—breast cancer	1.75e-06	1.52e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.73e-06	1.5e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CB—breast cancer	1.73e-06	1.5e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CB—breast cancer	1.72e-06	1.5e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTGS2—breast cancer	1.71e-06	1.49e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTGS2—breast cancer	1.71e-06	1.49e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CG—breast cancer	1.7e-06	1.48e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOA1—breast cancer	1.68e-06	1.46e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP19A1—breast cancer	1.66e-06	1.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—STK11—breast cancer	1.66e-06	1.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—COMT—breast cancer	1.54e-06	1.34e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTP1—breast cancer	1.53e-06	1.33e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PTEN—breast cancer	1.52e-06	1.33e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—HMOX1—breast cancer	1.51e-06	1.32e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ITPR1—breast cancer	1.51e-06	1.31e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PTEN—breast cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CD—breast cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PTEN—breast cancer	1.49e-06	1.3e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ALB—breast cancer	1.47e-06	1.28e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—PIK3CA—breast cancer	1.45e-06	1.27e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ABCB1—breast cancer	1.45e-06	1.26e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TYMS—breast cancer	1.42e-06	1.24e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—NOS3—breast cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NCOR1—breast cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GSTM1—breast cancer	1.41e-06	1.23e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—PIK3CA—breast cancer	1.35e-06	1.18e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—GPX1—breast cancer	1.35e-06	1.17e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CYP1A1—breast cancer	1.33e-06	1.16e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ERCC2—breast cancer	1.32e-06	1.15e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CB—breast cancer	1.3e-06	1.13e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTGS2—breast cancer	1.29e-06	1.12e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MTHFR—breast cancer	1.24e-06	1.08e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—AKT1—breast cancer	1.19e-06	1.03e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CAV1—breast cancer	1.15e-06	9.99e-06	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PTEN—breast cancer	1.12e-06	9.78e-06	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—AKT1—breast cancer	1.1e-06	9.62e-06	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—PIK3CA—breast cancer	1.07e-06	9.36e-06	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—PIK3CA—breast cancer	1.05e-06	9.17e-06	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—PIK3CA—breast cancer	1.05e-06	9.15e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CG—breast cancer	1.05e-06	9.1e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CD—breast cancer	9.19e-07	8e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ALB—breast cancer	9.07e-07	7.9e-06	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—AKT1—breast cancer	8.78e-07	7.64e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—NOS3—breast cancer	8.68e-07	7.56e-06	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—AKT1—breast cancer	8.6e-07	7.49e-06	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—AKT1—breast cancer	8.58e-07	7.47e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CB—breast cancer	8.01e-07	6.98e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTGS2—breast cancer	7.94e-07	6.91e-06	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—PIK3CA—breast cancer	7.93e-07	6.9e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PTEN—breast cancer	6.92e-07	6.03e-06	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—AKT1—breast cancer	6.47e-07	5.64e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—PIK3CA—breast cancer	4.88e-07	4.25e-06	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—AKT1—breast cancer	3.99e-07	3.47e-06	CbGpPWpGaD
